From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | Concentrations [µmol/L] | % of survivors | Percentage content of particular stages | |||
---|---|---|---|---|---|---|
Trophozoites | Cysts | Total | Trophozoites | Cysts | ||
7a | 5.5 | 23.3 ± 2.0 | 15.0 ± 2.3 | 22.5 ± 2.0 | 93.4 ± 8.0 | 6.6 ± 1.0 |
11.1 | 41.2 ± 2.8 | 76.0 ± 9.7 | 44.5 ± 3.5 | 83.6 ± 5.7 | 16.4 ± 2.1 | |
7b | 5.2 | 26.5 ± 2.3 | 19.0 ± 3.4 | 25.8 ± 2.4 | 92.7 ± 7.9 | 7.3 ± 1.3 |
7.9 | 22.0 ± 1.8 | 121.0 ± 12.6 | 31.6 ± 2.9 | 62.5 ± 5.2 | 37.5 ± 3.9 | |
Chlorohexidine | 4.4 | 23.4 ± 0.7 | 11.0 ± 1.6 | 22.3 ± 0.8 | 95.3 ± 2.9 | 4.7 ± 0.7 |
11.0 | 24.2 ± 1.1 | 31.0 ± 4.8 | 24.8 ± 2.6 | 88.4 ± 3.9 | 11.6 ± 1.8 |